Literature DB >> 22665417

Abnormalities of vascular structure and function in children with Perthes disease.

Daniel C Perry1, Daniel J Green, Colin E Bruce, Daniel Pope, Peter Dangerfield, Mary Jane Platt, Andrew J Hall, Helen Jones.   

Abstract

BACKGROUND AND OBJECTIVES: Perthes disease is a childhood precipitant to osteoarthritis of the hip, for which the etiology and mechanism are unknown. There is mounting evidence to suggest a vascular insult is responsible for disease, and it is suggested that this may have long-term implications for the vascular health of affected individuals. This study sought to use ultrasound measures to investigate vascular structure and function in children affected by Perthes disease.
METHODS: This case control study encompassed 149 cases and 146 controls, frequency matched for age and gender. Endothelial function was measured by using the technique of flow-mediated dilation of the brachial artery, and alterations in arterial flow were recorded in response to an ischemic stimulus.
RESULTS: There was a significant structural alteration in the vasculature among individuals with Perthes disease (resting brachial artery diameter (cases 2.97 mm versus controls 3.11 mm; P = .01), which remained even after adjusting for height. In addition, there was a notable reduction in blood velocity (cases 33.84 cm/s versus controls 37.83 cm/s; P = .01) and blood flow (cases 149.82 mL/min versus controls 184.67 mL/min; P = .001), which was independent of baseline arterial size. There was no evidence to suggest that flow-mediated dilation of the brachial artery was impaired among affected individuals (P = .71).
CONCLUSIONS: Children with Perthes disease exhibit small artery caliber and reduced function, which is independent of body composition. These data imply that that Perthes disease may reflect a wider vascular phenomenon that could have long-term implications for the vascular health of affected individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22665417     DOI: 10.1542/peds.2011-3269

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Unravelling the enigma of Perthes disease.

Authors:  D C Perry
Journal:  Ann R Coll Surg Engl       Date:  2013-07       Impact factor: 1.891

2.  Comparative study of serum proteomes in Legg-Calve-Perthes disease.

Authors:  Ruiyu Liu; Lihong Fan; Longbin Yin; Kunzheng Wang; Wusheng Miao; Qichun Song; Xiaoqian Dang; Hang Gao; Chuanyi Bai
Journal:  BMC Musculoskelet Disord       Date:  2015-10-05       Impact factor: 2.362

3.  New insights into the biomechanics of Legg-Calvé-Perthes' disease: The Role of Epiphyseal Skeletal Immaturity in Vascular Obstruction.

Authors:  M Pinheiro; C A Dobson; D Perry; M J Fagan
Journal:  Bone Joint Res       Date:  2018-02       Impact factor: 5.853

Review 4.  Legg-Calvé-Perthes disease overview.

Authors:  Armando O Rodríguez-Olivas; Edgar Hernández-Zamora; Elba Reyes-Maldonado
Journal:  Orphanet J Rare Dis       Date:  2022-03-15       Impact factor: 4.123

5.  Microarray analysis of lncRNA and mRNA expression profiles in patients with Legg-Calve-Perthes disease.

Authors:  Shangyu Wang; Haobo Zhong; Renhao Ze; Pan Hong; Jin Li; Xin Tang
Journal:  Front Pediatr       Date:  2022-09-07       Impact factor: 3.569

6.  The presentation of Legg-Calvé-Perthes disease in females.

Authors:  Andrew G Georgiadis; Mark A Seeley; Joseph L Yellin; Wudbhav N Sankar
Journal:  J Child Orthop       Date:  2015-07-26       Impact factor: 1.548

7.  Is Legg-Calvé-Perthes Disease a Local Manifestation of a Systemic Condition?

Authors:  Yasmin D Hailer; Nils P Hailer
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

8.  Improved Ultrasound Localization Microscopy Based on Microbubble Uncoupling via Transmit Excitation.

Authors:  Jihun Kim; Mathew R Lowerison; Nathiya V Chandra Sekaran; Zhengchang Kou; Zhijie Dong; Michael L Oelze; Daniel A Llano; Pengfei Song
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2022-03-02       Impact factor: 2.725

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.